Therapeutic potential of rosuvastatin in sepsis-induced acute kidney injury; evidence from an experimental animal study

Journal of Nephropharmacology · Published 2025-09-20 · DOI 10.34172/npj.2025.12798

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.34172/npj.2025.12798

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Evaluation of the effect of montelukast drug in improving the clinical condition of patients with COVID-19 in referral hospitals in Isfahan; a randomized clinical trial · Journal of Nephropharmacology · 2024 · Same journal
• Association between anti-erythropoietin antibody levels and treatment response in hemodialysis patients with end-stage renal disease: A cross-sectional study from Iraq · Journal of Nephropharmacology · 2025 · Same journal
• The Mayo Clinic consensus report on membranous nephropathy; a promising step toward better treating the disease · Journal of Nephropharmacology · 2024 · Same journal
• The efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) on renoprotection in lupus nephritis: a comprehensive review · Journal of Nephropharmacology · 2024 · Same journal
• Potential of a palladium–Mexidol complex in normalization of liver tests as a dual organoprotective of hepato-renal function in a paracetamol-induced rat model · Journal of Nephropharmacology · 2025 · Same journal
• Placenta, platelets, and podocytes; the triad of renal injury in pregnant women with antiphospholipid syndrome · Journal of Nephropharmacology · 2025 · Same journal
• Should a forgotten guidewire be removed after years? An undesirable complication of hemodialysis catheter wire left in the body · Journal of Nephropharmacology · 2023 · Same journal
• A mathematical analysis of dialysis report and kidney function tests; a case study · Journal of Nephropharmacology · 2023 · Same journal
• Renal insufficiency in breast cancer patients; a review study · Journal of Nephropharmacology · 2024 · Same journal
• Eculizumab in kidney diseases · Journal of Nephropharmacology · 2023 · Same journal